The share price is disappointing. However, the potential has not changed. Will recover when trials get closer I expect.
Jacob Hope is on hold with patents being pursued. Ex CEO seemed very fond of this project and has stated reason for leaving is to pursue non oncology drug development. Join the dots...
Isn't GK about 70? Probably wants to make the most of his remaining productive years.
- Forums
- ASX - By Stock
- KZA
- Ann: Novogen Announces Outcome of Comprehensive Science Review
Ann: Novogen Announces Outcome of Comprehensive Science Review, page-61
-
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)